ETIOLOGY, CLINICAL FEATURES AND PREVENTION OF CLOSTRIDIUM TETANI

Authors

  • Fayziyev Shohjaxon Xamza ugli,Aitmuratova Gauxar Abatovna Student, Assistant,Tashkent State Medical University

DOI:

https://doi.org/10.5281/zenodo.20176829

Keywords:

Clostridium tetani, tetanus, etiology, spore-forming bacterium, anaerobic microorganisms, neurotoxin, muscle spasm, trismus, immunoprophylaxis, toxoid vaccine, active immunization, infection.

Abstract

This article examines the main causes (etiology), clinical signs, and prevention measures of tetanus caused by the bacterium Clostridium tetani. C. tetani is a gram-positive, spore-forming, obligate anaerobic microorganism. It is mainly found in soil, dust, and animal intestines. Bacterial spores are resistant to the external environment; upon entering the body through a wound, they become active and produce a toxin.The neurotoxin secreted by the bacteria influences the development of tetanus. This toxin affects the nervous system, causing intense muscle contractions and spasms. Clinically, the disease manifests as triism, muscle rigidity, and general spasms. In preventive measures, primary attention is paid to active immunization. Anatoxin-based tetanus vaccines are utilized as highly effective prophylactic agents in the prevention of the disease. Furthermore, timely and proper treatment of wound surfaces and strict adherence to sanitary and hygienic standards are important factors in disease prevention.The article briefly outlines the general microbiological characteristics of tetanus, the course of the disease, and preventive measures based on scientific sources.

Downloads

Download data is not yet available.

References

1.Smith LDS. Clostridium tetani. In: Pathogenic Anaerobic Bacteria. 2nd ed. (American Lecture Series No. 980). Springfield, IL: Charles C. Thomas; 1975. p. 177–201.

2.Bytchenko B. Microbiology of tetanus. In: Veronesi R, editor. Tetanus: Important New Concepts. Amsterdam: Excerpta Medica; 1981. p. 28–39.

3.Hachisuka Y, et al. Effect of oxidation-reduction potential on germination, growth, and outgrowth of spores of Clostridium tetani, Clostridium butyricum, and Bacillus subtilis. Microbiology and Immunology. 1982;26:803–811.

4.Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7081504/

5.Smith LDS, Williams BL. Pathogenic Anaerobic Bacteria. 3rd ed. (American Lecture Series No. 1064). Springfield, IL: Charles C. Thomas; 1984.

6. Wilkins CA, et al. Occurrence of Clostridium tetani in soil and horses. South African Medical Journal. 1988;73:718–720.

7. Sathish S, Swaminathan K. Genetic diversity among toxigenic clostridia isolated from soil, water, meat, and associated polluted sites in South India. Indian Journal of Medical Microbiology. 2009;27:311–320.

8. Kobayashi T, et al. Distribution of Clostridium botulinum and Clostridium tetani in Okinawa Prefecture. Kansenshogaku Zasshi. 1992;66:1639–1644. (in Japanese)

9. Haneda J, et al. Distribution of Clostridium tetani in soil layers of Sagamihara, central Japan. Kansenshogaku Zasshi. 2006;80:690–693. (in Japanese)

10. Ebisawa I, et al. Density and distribution of Clostridium tetani in soil. Japanese Journal of Experimental Medicine. 1986;56:69–74.

11. Keyel PA, et al. Macrophage responses to bacterial toxins: balancing activation and suppression. Immunologic Research. 2011;50:118–123.

12. Wright GP. The neurotoxins of Clostridium botulinum and Clostridium tetani. Pharmacological Reviews. 1955;7:413–465.

13. Masuyer G, et al. Structure of tetanus toxin reveals pH-mediated domain dynamics. EMBO Reports. 2017;18:1306–1317.

14. Burkitt JM, et al. Risk factors associated with outcome in dogs with tetanus: 38 cases (1987–2005). Journal of the American Veterinary Medical Association. 2007;230:76–83.

15. Coetzee JF, et al. Survey of castration methods and associated livestock management practices performed by bovine veterinarians in the United States. BMC Veterinary Research. 2010;6:12.

Downloads

Published

2026-05-14

Issue

Vol. 5 No. 5 (2026): Journal of Multidisciplinary Sciences and Innovations

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

ETIOLOGY, CLINICAL FEATURES AND PREVENTION OF CLOSTRIDIUM TETANI. (2026). Journal of Multidisciplinary Sciences and Innovations, 5(5), 945-955. https://doi.org/10.5281/zenodo.20176829

Similar Articles

21-30 of 668

You may also start an advanced similarity search for this article.